AU4656997A - Method for inhibiting tumor angiogenesis in a living subject - Google Patents

Method for inhibiting tumor angiogenesis in a living subject

Info

Publication number
AU4656997A
AU4656997A AU46569/97A AU4656997A AU4656997A AU 4656997 A AU4656997 A AU 4656997A AU 46569/97 A AU46569/97 A AU 46569/97A AU 4656997 A AU4656997 A AU 4656997A AU 4656997 A AU4656997 A AU 4656997A
Authority
AU
Australia
Prior art keywords
inhibiting tumor
tumor angiogenesis
living subject
living
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46569/97A
Inventor
Kevin P. Claffey
Michael Detmar
Donald R. Senger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Center Inc filed Critical Beth Israel Deaconess Medical Center Inc
Publication of AU4656997A publication Critical patent/AU4656997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU46569/97A 1997-09-30 1997-09-30 Method for inhibiting tumor angiogenesis in a living subject Abandoned AU4656997A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/017485 WO1999016465A1 (en) 1997-09-30 1997-09-30 Method for inhibiting tumor angiogenesis in a living subject

Publications (1)

Publication Number Publication Date
AU4656997A true AU4656997A (en) 1999-04-23

Family

ID=22261769

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46569/97A Abandoned AU4656997A (en) 1997-09-30 1997-09-30 Method for inhibiting tumor angiogenesis in a living subject

Country Status (2)

Country Link
AU (1) AU4656997A (en)
WO (1) WO1999016465A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387779B2 (en) 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US6759047B1 (en) 1998-06-17 2004-07-06 Beth Israel Deaconess Hospital Corp. Anti-angiogenic proteins and methods of use thereof
US6962974B1 (en) 1998-06-17 2005-11-08 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US7740841B1 (en) 2000-01-28 2010-06-22 Sunnybrook Health Science Center Therapeutic method for reducing angiogenesis
AU2005250188A1 (en) 2004-06-02 2005-12-15 Valtion Teknillinen Tutkimuskeskus Method for activating of T cell protein tyrosine phosphatase and therapeutical methods based thereon
BRPI0609509A2 (en) 2005-03-30 2010-04-13 Conforma Therapeutics Corp pharmaceutically acceptable compound or a polymorph, solvate, tautomer, enantiomer, prodrug or salt thereof, pharmaceutical composition, and, use of the pharmaceutically acceptable compound, polymorph, solvate, tautomer, enantiomer, prodrug or salt
AU2006283174A1 (en) * 2005-08-24 2007-03-01 Cell-Matrix, Inc. Combination therapies for inhibiting integrin-extracellular matrix interactions
US7585865B2 (en) 2006-07-21 2009-09-08 The Penn State Research Foundation Protein kinase C zeta inhibition to treat vascular permeability
WO2008142198A2 (en) * 2007-05-23 2008-11-27 Valtion Teknillinen Tutkimuskeskus A method for inhibiting or stimulating angiogenesis in an individual

Also Published As

Publication number Publication date
WO1999016465A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
HUP9904666A3 (en) Therapy for alpa-galactosidase a deficiency
AU9227198A (en) A method for improving skin condition
HUP0000911A3 (en) Refuse-treatment method
GB2345063B (en) Method
GB9721603D0 (en) Method
AU8696398A (en) Automated abrader
GB9706282D0 (en) Method
GB9702592D0 (en) Selection method
GB9700320D0 (en) Method
AU4656997A (en) Method for inhibiting tumor angiogenesis in a living subject
GB9713283D0 (en) Method for preparing aminoalkoxysiloxanes
ZA985308B (en) Irrigation method
GB9707744D0 (en) Method
GB9717652D0 (en) Method
IL134507A0 (en) Method for preparing oxazaphosphorin-2-amines
GB9709811D0 (en) Method
GB9702510D0 (en) Selection method
GB9702591D0 (en) Selection method
GB9702576D0 (en) Selection method
GB9702539D0 (en) Selection method
AU126488S (en) A mausoleum
AUPO656497A0 (en) Inlay method for acrylic benchtops
AU128599S (en) A coffin
AU128601S (en) A coffin
AUPO721497A0 (en) A method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase